Your browser doesn't support javascript.
Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network.
Colling, Richard; Protheroe, Andrew; Sullivan, Mark; Macpherson, Ruth; Tuthill, Mark; Redgwell, Jacqueline; Traill, Zoe; Molyneux, Angus; Johnson, Elizabeth; Abdullah, Niveen; Taibi, Andrea; Mercer, Nikki; Haynes, Harry R; Sackville, Anthony; Craft, Judith; Reis, Joao; Rees, Gabrielle; Soares, Maria; Roberts, Ian S D; Siiankoski, Darrin; Hemsworth, Helen; Roskell, Derek; Roberts-Gant, Sharon; White, Kieron; Rittscher, Jens; Davies, Jim; Browning, Lisa; Verrill, Clare.
  • Colling R; Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK.
  • Protheroe A; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Sullivan M; Department of Oncology, University of Oxford, Oxford OX3 9DU, UK.
  • Macpherson R; Oxford Cancer Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Tuthill M; Urology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Redgwell J; Radiology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Traill Z; Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Molyneux A; Urology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Johnson E; Radiology Department, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Abdullah N; Pathology Department, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes MK6 5DL, UK.
  • Taibi A; Pathology Department, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes MK6 5DL, UK.
  • Mercer N; Pathology Department, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes MK6 5DL, UK.
  • Haynes HR; Department of Cellular Pathology, North Bristol NHS Trust, Bristol BS10 5NB, UK.
  • Sackville A; Department of Cellular Pathology, Great Western Hospitals NHS Foundation Trust, Swindon SN3 6BB, UK.
  • Craft J; Department of Cellular Pathology, Great Western Hospitals NHS Foundation Trust, Swindon SN3 6BB, UK.
  • Reis J; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Rees G; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Soares M; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Roberts ISD; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Siiankoski D; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Hemsworth H; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Roskell D; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Roberts-Gant S; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • White K; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Rittscher J; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Davies J; Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 9DU, UK.
  • Browning L; Institute of Biomedical Engineering, University of Oxford, Oxford OX3 7DQ, UK.
  • Verrill C; Department of Computer Science, University of Oxford, Oxford OX1 2JD, UK.
Diagnostics (Basel) ; 11(12)2021 Nov 25.
Article in English | MEDLINE | ID: covidwho-1592467
ABSTRACT

BACKGROUND:

In this article we share our experience of creating a digital pathology (DP) supraregional germ cell tumour service, including full digitisation of the central laboratory.

METHODS:

DP infrastructure (Philips) was deployed across our hospital network to allow full central digitisation with partial digitisation of two peripheral sites in the supraregional testis germ cell tumour network. We used a survey-based approach to capture the quantitative and qualitative experiences of the multidisciplinary teams involved.

RESULTS:

The deployment enabled case sharing for the purposes of diagnostic reporting, second opinion, and supraregional review. DP was seen as a positive step forward for the departments involved, and for the wider germ cell tumour network, and was completed without significant issues. Whilst there were challenges, the transition to DP was regarded as worthwhile, and examples of benefits to patients are already recognised.

CONCLUSION:

Pathology networks, including highly specialised services, such as in this study, are ideally suited to be digitised. We highlight many of the benefits but also the challenges that must be overcome for such clinical transformation. Overall, from the survey, the change was seen as universally positive for our service and highlights the importance of engagement of the whole team to achieve success.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Qualitative research Language: English Year: 2021 Document Type: Article Affiliation country: Diagnostics11122191

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study / Qualitative research Language: English Year: 2021 Document Type: Article Affiliation country: Diagnostics11122191